FDA Suddenly Pulls Monoclonal Antibody Treatment EUAs: ‘They are Not a Substitute for Vaccination’
The Food and Drug Administration suddenly rescinded the Emergency Use Authorization (EUAs) for a number of monoclonal antibody treatments that have been used for early treatment of Covid-19. The Florida Department of Health made the announcement about the FDA’s “abrupt decision” to pull the EUAs for bamlanivimab/etesevimab as well as Regeneron. The decision has led …